Fátima Langa

Recent publications · Crossref

5 total works indexed

1. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

   · 2012 · cited 4,393x

2. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

   · 2019 · cited 2,303x

3. New insights into the genetic etiology of Alzheimer’s disease and related dementias

   · 2022 · cited 2,202x

4. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism

   · 2020 · cited 2,140x

5. Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis

   · 2010 · cited 2,133x

via Crossref · CC0